Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) adjuvanted vaccine in older adults with chronic obstructive pulmonary disease (COPD)

Conclusion: NTHi vaccine has an acceptable safety profile, induces substantial increases in humoral responses and moderate CD4+ T-cell responses.Funding: GlaxoSmithKline Biologicals SA

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Wilkinson, T., Schembri, S., Brightling, C., Bakerly, N. D., Macnee, W., Rombo, L., Hedner, J., Allen, M., Walker, P., De Ryck, I., Tasciotti, A., Casula, D., Testa, M., Arora, A. K. Tags: Clinical Problems Source Type: research